Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

May 01, 2023 08:00 ET | Source: Ring Therapeutics

Ring Therapeutics Strengthens Executive Team with Appointment of Christopher McNulty as Chief Financial Officer, Head of Corporate Strategy

McNulty brings deep experience in capital formation and business development to Ring Follows recent appointment of Dr. Christopher Wright as Chief Medical Officer CAMBRIDGE, Mass., May 01, 2023 ...
March 09, 2023 06:30 ET | Source: Ring Therapeutics

Ring Therapeutics Raises $86.5 Million in Series C Funding to Create Next Generation Programmable Medicines

– Ring raised a total of $86.5 million from new and returning investors, validating its unique approach to creating next-generation programable genetic medicines – – The proceeds from this raise will...
January 30, 2023 08:00 ET | Source: Ring Therapeutics

Ring Therapeutics Announces Appointment of Industry Veteran Christopher Wright, M.D., Ph.D. as Chief Medical Officer, Head of Translational Research

CAMBRIDGE, Mass., Jan. 30, 2023 (GLOBE NEWSWIRE) -- Ring Therapeutics, a life sciences company founded by Flagship Pioneering to revolutionize gene therapy with its commensal virome platform, today...
September 20, 2022 08:00 ET | Source: Ring Therapeutics

Ring Therapeutics Announces Issuance of U.S. Patent for its Anellovector™ Compositions

CAMBRIDGE, Mass., Sept. 20, 2022 (GLOBE NEWSWIRE) -- Ring Therapeutics, a life sciences company founded by Flagship Pioneering to revolutionize gene therapy with its commensal virome platform, today...
July 18, 2022 08:00 ET | Source: Ring Therapeutics

Ring Therapeutics Announces Three Presentations at the 41st Annual Meeting of the American Society for Virology (ASV)

CAMBRIDGE, Mass., July 18, 2022 (GLOBE NEWSWIRE) -- Ring Therapeutics, a life sciences company founded by Flagship Pioneering to revolutionize gene therapy with its commensal virome platform, today...
July 06, 2022 08:00 ET | Source: Ring Therapeutics

Ring Therapeutics Publishes the First Human Anellovirus Structure with Key Insights on Its Assembly, Function and Immune Evasion Properties

– New data describe the first structure of anellovirus particles, including a novel jelly roll domain architecture – – Structural analyses suggest mechanism of anellovirus immune evasion that may...
May 03, 2022 08:00 ET | Source: Ring Therapeutics

Ring Therapeutics Announces Two Presentations at the Upcoming 25th Annual Meeting of the American Society of Gene & Cell Therapy (ASGCT)

CAMBRIDGE, Mass., May 03, 2022 (GLOBE NEWSWIRE) -- Ring Therapeutics, a life sciences company founded by Flagship Pioneering to revolutionize gene therapy with its AnellogyTM commensal virome...
May 02, 2022 08:00 ET | Source: Ring Therapeutics

Ring Therapeutics Announces Publication Highlighting In Vivo Delivery and Tropism of the First Synthesized Human Anelloviruses Using a Recombinant Genome

CAMBRIDGE, Mass., May 02, 2022 (GLOBE NEWSWIRE) -- Ring Therapeutics, a life sciences company founded by Flagship Pioneering to revolutionize gene therapy with its AnellogyTM commensal virome...
March 31, 2022 08:00 ET | Source: Ring Therapeutics

Ring Therapeutics Announces Publication Highlighting the Immune Favorability of Commensal Anelloviruses

– First description of new, comprehensive anellovirus antibody analysis tool, AnelloScan – – Cross-sectional study supports that anelloviruses are associated with weaker immune responses compared...
March 17, 2022 08:00 ET | Source: Ring Therapeutics

Ring Therapeutics Announces the Appointment of Industry Leaders to its Board of Directors

CAMBRIDGE, Mass., March 17, 2022 (GLOBE NEWSWIRE) -- Ring Therapeutics, a life sciences company founded by Flagship Pioneering to revolutionize gene therapy with its commensal virome platform, today...